Causes of 2007 (great) Recession.
Causes of 2007 (great) Recession.
From the Conclusion below.
The U.S. Financial Crisis Inquiry Commission reported its findings in January 2011. It concluded that "the crisis was avoidable and was caused by: Widespread failures in financial regulation, including the Federal Reserve’s failure to stem the tide of toxic mortgages; Dramatic breakdowns in corporate governance including too many financial firms acting recklessly and taking on too much risk; An explosive mix of excessive borrowing and risk by households and Wall Street that put the financial system on a collision course with crisis; Key policy makers ill prepared for the crisis, lacking a full understanding of the financial system they oversaw; and systemic breaches in accountability and ethics at all levels
Many factors directly and indirectly caused the Great Recession (which started in 2007 with the US subprime mortgage crisis), with experts and economists placing different weights on particular causes .
Major causes of the initial subprime mortgage crisis and following recession include: International trade imbalances and tax lending standards contributing to high levels of developed country household debt and real-estate bubbles that have since burst; U.S. government housing policies; and limited regulation of non-depository financial institutions. Once the recession began, various responses were attempted with different degrees of success. These included fiscal policies of governments; monetary policies of central banks; measures designed to help indebted consumers refinance their mortgage debt; and inconsistent approaches used by nations to bail out troubled banking industries and private bondholders, assuming private debt burdens or socializing losses.
One narrative describing the causes of the crisis begins with the significant increase in savings available for investment during the 2000–2007 period when the global pool of fixed-income securities increased from approximately $36 trillion in 2000 to $80 trillion by 2007. This "Giant Pool of Money" increased as savings from high-growth developing nations entered global capital markets. Investors searching for higher yields than those offered by U.S. Treasury bonds sought alternatives globally.[1]
The temptation offered by such readily available savings overwhelmed the policy and regulatory control mechanisms in country after country, as lenders and borrowers put these savings to use, generating bubble after bubble across the globe.
While these bubbles have burst, causing asset prices (e.g., housing and commercial property) to decline, the liabilities owed to global investors remain at full price, generating questions regarding the solvency of consumers, governments and banking systems.[2] The effect of this debt overhang is to slow consumption and therefore economic growth and is referred to as a "balance sheet recession" or debt-deflation.[3]
The fall in asset prices (such as subprime mortgage-backed securities) during 2007 and 2008 caused the equivalent of a bank run on the U.S. shadow banking system, which includes investment banks and other non-depository financial entities. This system had grown to rival the depository system in scale yet was not subject to the same regulatory safeguards.[3] Struggling banks in the U.S. and Europe cut back lending causing a credit crunch. Consumers and some governments were no longer able to borrow and spend at pre-crisis levels. Businesses also cut back their investments as demand faltered and reduced their workforces. Higher unemployment due to the recession made it more difficult for consumers and countries to honor their obligations. This caused financial institution losses to surge, deepening the credit crunch, thereby creating an adverse feedback loop.[4]
The U.S. Financial Crisis Inquiry Commission reported its findings in January 2011. It concluded that "the crisis was avoidable and was caused by: Widespread failures in financial regulation, including the Federal Reserve’s failure to stem the tide of toxic mortgages; Dramatic breakdowns in corporate governance including too many financial firms acting recklessly and taking on too much risk; An explosive mix of excessive borrowing and risk by households and Wall Street that put the financial system on a collision course with crisis; Key policy makers ill prepared for the crisis, lacking a full understanding of the financial system they oversaw; and systemic breaches in accountability and ethics at all levels
(0)
(0)
Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Big Copper Moves at La Verde: What's New? Look, when it comes to copper, Hot Chili Limited is throwing down some serious markers. You see, their La Verde project is turning into a hotbed of activity thanks to their latest drilling revelations. They've managed to confirm a second porphyry center, which is like finding another gold mine, except with copper. This essentially...
Continue Reading
Blue Moon Metals' Acquisition Detour Blue Moon Metals Inc. (NASDAQ: BMM), a name that's been stirring up chatter for its ambitious mining ventures, has waved goodbye to its planned acquisition of 33 U.S.-based tungsten and antimony projects. This move, announced on October 30, 2026, may have caught some investors off guard. The acquisition sounded like a good fit: a...
Continue Reading
Another Day, Another Lawsuit Ah, work. It’s what gets us up in the morning, whether we like it or not. Yet, for many, it can feel more like a dubious hustle when the rewards don't match the effort. Now, CMRE Financial Services, Inc. finds itself under the legal microscope, thanks to a fresh class-action lawsuit filed by the legal eagles at Blumenthal Nordrehaug Bhowmik...
Continue Reading
Brewers: Finally on Top of the World Boy oh boy, the Milwaukee Brewers have finally done it! After years of being the underdogs, the team has clinched their first-ever World Series championship in 2026. You think you're dreaming, but no, it's the real deal. The Brewers, once just a hopeful name on the roster of Major League Baseball's teams, have stormed their way to a...
Continue Reading
California's Alert: Labor Code Violations Under Scrutiny Allegations like these can shake things up pretty quick, especially when you're dealing with harsh financial climates. Aemetis Advanced Fuel Keyes, Inc. is in hot water yet again—this time, they're being called out for allegedly messing up the wage game for their workers. That's right, a class action lawsuit filed...
Continue Reading
From the Shadows to the Spotlight Ever seen someone step up to the plate and knock it out of the park? That's what the United Breast Cancer Foundation (UBCF) is doing by plastering their mission right across Times Square. Talk about grabbing the bull by the horns, eh? With not one, but two billboards now gracing one of the globe's most iconic public spaces, they've...
Continue Reading
Mobile 3D Scanning — Finally, Some Real Innovation Gone are the days where engineers had to cart around bulky laptops just to finish a simple inspection. SCANOLOGY has thrown a real game-changer into the mix with their new AirGO Pad. It's essentially a slick tablet that keeps your scanning, inspecting, and reporting all in one place, right beside whatever tangled hunk...
Continue Reading
New Spin on an Old Favorite: Rice Noodles Forget about the same old wheat noodles clogging up the pantry. HanAll F&B is revamping the noodle game with a homegrown twist, setting sights on a future where Korean rice isn't just for steaming, soup, or sushi. This outfit from Taebaek, Gangwon, has got its hands deep in the rice flour, finessing a patent that aims to make...
Continue Reading
Pivotal Point for Zhimeng's ALS Efforts Folks, get this—Zhimeng Biopharma's rolling out the big guns here with a significant step forward in their ALS treatment quest. This company just wrapped up patient enrollment for their next-gen ALS drug, CB03-154. We're talking about 255 patients now on board for a Phase 2/3 trial. The ground's shaking a bit because this...
Continue Reading
Behind Closed Doors: PRTH's Merger Drama Unfolds The market's got its share of tricky maneuvers and right now, Priority Technology Holdings, Inc. (NASDAQ:PRTH) is under the magnifying glass. Levi & Korsinsky, LLP has kicked off an investigation into the nitty-gritty of PRTH's acquisition by its largest shareholder—none other than their own Chairman and CEO, Thomas C....
Continue Reading
Top 5 Most Recently Viewed Articles
Marc Terwilliger Joins Fleet Team as Vice President Fleet Team, a leader in fleet management and consulting, is excited to share the news of Marc Terwilliger's appointment as Vice President of Warehouse Systems. With nearly 20 years of experience in material handling and warehousing, Marc is set to make a significant impact on innovation and operational excellence within...
Continue Reading
Zenni Optical Launches EyeQLenz™ with Zenni ID Guard™ Zenni Optical recently introduced EyeQLenz™ with Zenni ID Guard™, an innovative lens designed to enhance eye protection and privacy. Following this exciting launch, Zenni hosted a panel discussion featuring thought leaders from technology and digital culture. This expert panel addressed how to navigate the...
Continue Reading
New Campaign Inspires First-Time Homebuyers New American Funding (NAF), a prominent independent mortgage lender, is breaking new ground with its latest campaign aimed at revitalizing the home-buying experience for the next generation. The initiative, dubbed "Hell Yeah You're Buying a Home," is designed to ignite enthusiasm and confidence in first-time homebuyers,...
Continue Reading
Monk Fruit Sweeteners Market Growth Overview The monk fruit sweeteners market is witnessing a significant transformation, spurred by health-conscious consumers seeking natural alternatives to sugar. This market is projected to experience a steady growth trajectory, reaching a remarkable $147.2 million by 2032. The expected compound annual growth rate (CAGR) is estimated...
Continue Reading
Celldex Therapeutics (NASDAQ: CLDX) found itself in the spotlight back in 2024 when TD Cowen maintained a Buy rating on its shares following a detailed review of long-term data concerning barzolvolimab, a treatment for Chronic Spontaneous Urticaria (CSU). The standout here? The drug showcased a jaw-dropping complete response (CR) rate hitting 71% at the 52-week mark. Now...
Continue Reading